1. Home
  2. CVE Database
  3. CVE-2025-61940
HIGH · 8.3

CVE-2025-61940

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication chec...

Vulnerability Description

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.

CVSS Score

8.3

HIGH

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality
HIGH
Integrity
HIGH
Availability
LOW

Affected Products

VendorProductVersions
MirionBiodose\/Nmis< 23.0

Related Weaknesses (CWE)

CWE-603

References

FAQ

What is CVE-2025-61940?

CVE-2025-61940 is a vulnerability with a CVSS score of 8.3 (HIGH). NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication chec...

How severe is CVE-2025-61940?

CVE-2025-61940 has been rated HIGH with a CVSS base score of 8.3/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2025-61940?

Check the references section above for vendor advisories and patch information. Affected products include: Mirion Biodose\/Nmis.